The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.